"Successful Aging"

Effect of Subclinical Cardiovascular Disease

Anne B. Newman, Alice M. Arnold, Barbara L. Naydeck, Linda P Fried, Gregory L. Burke, Paul Enright, John Gottdiener, Calvin Hirsch, Daniel O'Leary, Russell Tracy

Research output: Contribution to journalArticle

Abstract

Background: Cardiovascular diseases are the primary cause of death in older adults. Among those without clinical disease, high levels of subclinical disease are associated with poor survival. The effect of the extent of subclinical cardiovascular disease on the quality of the remaining years has not been defined. Methods: In a longitudinal cohort study, 2932 men and women aged 65 years and older were followed up for 8 years to determine the likelihood of maintaining intact health and functioning. Successful aging was defined as remaining free of cardiovascular disease, cancer, and chronic obstructive pulmonary disease and with intact physical and cognitive functioning. Results: Younger age at study entry and a lower extent of subclinical cardiovascular disease were independently associated with the likelihood of maintaining successful aging. In age-stratified summaries, those with subclinical disease had a trajectory of decline similar to subjects 5 years older without subclinical vascular disease. Regression analyses showed that the decline associated with subclinical disease was equivalent to 6.5 (95% confidence interval, 6.4-6.6) years of aging for women and 5.6 (95% confidence interval, 5.4-5.8) years of aging for men. Individual measures of the extent of cardiovascular disease, diabetes mellitus, smoking, and higher C-reactive protein level were also independently predictive of fewer years of successful aging, but none of these factors substantially attenuated the effect of age itself. Conclusions: There is a graded relationship between the extent of vascular disease measured noninvasively and the likelihood of maintaining intact health and function. Prevention of subclinical vascular disease may increase the quality and the quantity of years in late life.

Original languageEnglish (US)
Pages (from-to)2315-2322
Number of pages8
JournalArchives of Internal Medicine
Volume163
Issue number19
DOIs
StatePublished - Oct 27 2003

Fingerprint

Cardiovascular Diseases
Vascular Diseases
Confidence Intervals
Health
C-Reactive Protein
Chronic Obstructive Pulmonary Disease
Longitudinal Studies
Cause of Death
Diabetes Mellitus
Cohort Studies
Smoking
Regression Analysis
Survival
Neoplasms

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Newman, A. B., Arnold, A. M., Naydeck, B. L., Fried, L. P., Burke, G. L., Enright, P., ... Tracy, R. (2003). "Successful Aging": Effect of Subclinical Cardiovascular Disease. Archives of Internal Medicine, 163(19), 2315-2322. https://doi.org/10.1001/archinte.163.19.2315

"Successful Aging" : Effect of Subclinical Cardiovascular Disease. / Newman, Anne B.; Arnold, Alice M.; Naydeck, Barbara L.; Fried, Linda P; Burke, Gregory L.; Enright, Paul; Gottdiener, John; Hirsch, Calvin; O'Leary, Daniel; Tracy, Russell.

In: Archives of Internal Medicine, Vol. 163, No. 19, 27.10.2003, p. 2315-2322.

Research output: Contribution to journalArticle

Newman, AB, Arnold, AM, Naydeck, BL, Fried, LP, Burke, GL, Enright, P, Gottdiener, J, Hirsch, C, O'Leary, D & Tracy, R 2003, '"Successful Aging": Effect of Subclinical Cardiovascular Disease', Archives of Internal Medicine, vol. 163, no. 19, pp. 2315-2322. https://doi.org/10.1001/archinte.163.19.2315
Newman, Anne B. ; Arnold, Alice M. ; Naydeck, Barbara L. ; Fried, Linda P ; Burke, Gregory L. ; Enright, Paul ; Gottdiener, John ; Hirsch, Calvin ; O'Leary, Daniel ; Tracy, Russell. / "Successful Aging" : Effect of Subclinical Cardiovascular Disease. In: Archives of Internal Medicine. 2003 ; Vol. 163, No. 19. pp. 2315-2322.
@article{29d66bd0416f402f9fda7daa68d49603,
title = "{"}Successful Aging{"}: Effect of Subclinical Cardiovascular Disease",
abstract = "Background: Cardiovascular diseases are the primary cause of death in older adults. Among those without clinical disease, high levels of subclinical disease are associated with poor survival. The effect of the extent of subclinical cardiovascular disease on the quality of the remaining years has not been defined. Methods: In a longitudinal cohort study, 2932 men and women aged 65 years and older were followed up for 8 years to determine the likelihood of maintaining intact health and functioning. Successful aging was defined as remaining free of cardiovascular disease, cancer, and chronic obstructive pulmonary disease and with intact physical and cognitive functioning. Results: Younger age at study entry and a lower extent of subclinical cardiovascular disease were independently associated with the likelihood of maintaining successful aging. In age-stratified summaries, those with subclinical disease had a trajectory of decline similar to subjects 5 years older without subclinical vascular disease. Regression analyses showed that the decline associated with subclinical disease was equivalent to 6.5 (95{\%} confidence interval, 6.4-6.6) years of aging for women and 5.6 (95{\%} confidence interval, 5.4-5.8) years of aging for men. Individual measures of the extent of cardiovascular disease, diabetes mellitus, smoking, and higher C-reactive protein level were also independently predictive of fewer years of successful aging, but none of these factors substantially attenuated the effect of age itself. Conclusions: There is a graded relationship between the extent of vascular disease measured noninvasively and the likelihood of maintaining intact health and function. Prevention of subclinical vascular disease may increase the quality and the quantity of years in late life.",
author = "Newman, {Anne B.} and Arnold, {Alice M.} and Naydeck, {Barbara L.} and Fried, {Linda P} and Burke, {Gregory L.} and Paul Enright and John Gottdiener and Calvin Hirsch and Daniel O'Leary and Russell Tracy",
year = "2003",
month = "10",
day = "27",
doi = "10.1001/archinte.163.19.2315",
language = "English (US)",
volume = "163",
pages = "2315--2322",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "19",

}

TY - JOUR

T1 - "Successful Aging"

T2 - Effect of Subclinical Cardiovascular Disease

AU - Newman, Anne B.

AU - Arnold, Alice M.

AU - Naydeck, Barbara L.

AU - Fried, Linda P

AU - Burke, Gregory L.

AU - Enright, Paul

AU - Gottdiener, John

AU - Hirsch, Calvin

AU - O'Leary, Daniel

AU - Tracy, Russell

PY - 2003/10/27

Y1 - 2003/10/27

N2 - Background: Cardiovascular diseases are the primary cause of death in older adults. Among those without clinical disease, high levels of subclinical disease are associated with poor survival. The effect of the extent of subclinical cardiovascular disease on the quality of the remaining years has not been defined. Methods: In a longitudinal cohort study, 2932 men and women aged 65 years and older were followed up for 8 years to determine the likelihood of maintaining intact health and functioning. Successful aging was defined as remaining free of cardiovascular disease, cancer, and chronic obstructive pulmonary disease and with intact physical and cognitive functioning. Results: Younger age at study entry and a lower extent of subclinical cardiovascular disease were independently associated with the likelihood of maintaining successful aging. In age-stratified summaries, those with subclinical disease had a trajectory of decline similar to subjects 5 years older without subclinical vascular disease. Regression analyses showed that the decline associated with subclinical disease was equivalent to 6.5 (95% confidence interval, 6.4-6.6) years of aging for women and 5.6 (95% confidence interval, 5.4-5.8) years of aging for men. Individual measures of the extent of cardiovascular disease, diabetes mellitus, smoking, and higher C-reactive protein level were also independently predictive of fewer years of successful aging, but none of these factors substantially attenuated the effect of age itself. Conclusions: There is a graded relationship between the extent of vascular disease measured noninvasively and the likelihood of maintaining intact health and function. Prevention of subclinical vascular disease may increase the quality and the quantity of years in late life.

AB - Background: Cardiovascular diseases are the primary cause of death in older adults. Among those without clinical disease, high levels of subclinical disease are associated with poor survival. The effect of the extent of subclinical cardiovascular disease on the quality of the remaining years has not been defined. Methods: In a longitudinal cohort study, 2932 men and women aged 65 years and older were followed up for 8 years to determine the likelihood of maintaining intact health and functioning. Successful aging was defined as remaining free of cardiovascular disease, cancer, and chronic obstructive pulmonary disease and with intact physical and cognitive functioning. Results: Younger age at study entry and a lower extent of subclinical cardiovascular disease were independently associated with the likelihood of maintaining successful aging. In age-stratified summaries, those with subclinical disease had a trajectory of decline similar to subjects 5 years older without subclinical vascular disease. Regression analyses showed that the decline associated with subclinical disease was equivalent to 6.5 (95% confidence interval, 6.4-6.6) years of aging for women and 5.6 (95% confidence interval, 5.4-5.8) years of aging for men. Individual measures of the extent of cardiovascular disease, diabetes mellitus, smoking, and higher C-reactive protein level were also independently predictive of fewer years of successful aging, but none of these factors substantially attenuated the effect of age itself. Conclusions: There is a graded relationship between the extent of vascular disease measured noninvasively and the likelihood of maintaining intact health and function. Prevention of subclinical vascular disease may increase the quality and the quantity of years in late life.

UR - http://www.scopus.com/inward/record.url?scp=0142150152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142150152&partnerID=8YFLogxK

U2 - 10.1001/archinte.163.19.2315

DO - 10.1001/archinte.163.19.2315

M3 - Article

VL - 163

SP - 2315

EP - 2322

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 19

ER -